Aberrant SATB1 expression is associated with Epstein-Barr virus infection, metastasis and survival in human nasopharyngeal cells and endemic nasopharyngeal carcinoma

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 5, 2014, Pages 2454-2461

  Deng, Yan Fei ^a,b   Zhou, Dong Ni ^a   Pan, Zhi Yong ^b   Yin, Ping ^a  

^a XIAMEN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Immunohistochemistry; Nasopharyngeal carcinoma; Prognosis; Quantitative real time PCR; SATB1

Indexed keywords

MATRIX ATTACHMENT REGION BINDING PROTEIN; MESSENGER RNA; SATB1 PROTEIN, HUMAN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; BIOPSY; CANCER STAGING; CARCINOMA; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CHINA; DISEASE FREE SURVIVAL; ENDEMIC DISEASE; EPIDEMIOLOGY; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NASOPHARYNX TUMOR; PATHOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SECONDARY; TIME; TUMOR CELL LINE; TUMOR RECURRENCE; UPREGULATION; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOPSY; CARCINOMA; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CHI-SQUARE DISTRIBUTION; CHINA; DISEASE-FREE SURVIVAL; ENDEMIC DISEASES; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MATRIX ATTACHMENT REGION BINDING PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 84902436517     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Mir R, Pradhan SJ, Galande S. Chromatin organizer SATB1 as a novel molecular target for cancer therapy. Curr Drug Targets 2012; 13: 1603-15.
2. Kohwi-Shigematsu T, Poterlowicz K, Ordinario E, Han HJ, Botchkarev VA, Kohwi Y. Genome organizing function of SATB1 in tumor progression. Semin Cancer Biol 2013; 23: 72-9.
3. Nodin B, Hedner C, Uhlén M, Jirström K. Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer. J Ovarian Res 2012; 5: 24.
4. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008; 452: 187-93.
5. Nodin B, Johannesson H, Wangefjord S, O'Connor DP, Lindquist KE, Uhlén M, Jirström K, Eberhard J. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer. Diagn Pathol 2012; 7: 115.
6. Zhao XD, Ji WY, Zhang W, He LX, Yang J, Liang HJ, Wang LL. Overexpression of SATB1 in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2010; 72: 1-5.
7. Lu X, Cheng C, Zhu S, Yang Y, Zheng L, Wang G, Shu X, Wu K, Liu K, Tong Q. SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Oncol Rep 2010; 24: 981-7.
8. Mao L, Yang C, Wang J, Li W, Wen R, Chen J, Zheng J. SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion. J Transl Med 2013; 11: 111.
9. Han B, Luan L, Xu Z, Wu B. Expression and biological roles of SATB1 in human bladder cancer. Tumour Biol 2013; 34: 2943-9.
10. Selinger CI, Cooper WA, Al-Sohaily S, Mladenova DN, Pangon L, Kennedy CW, McCaughan BC, Stirzaker C, Kohonen-Corish MR. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer. J Thorac Oncol 2011; 6: 1179-89.
11. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization classification of tumors: pathology and genetics of head and neck tumors. Lyon: IARC Press, 2005; pp: 81-106.
12. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8.
13. Hanker LC, Karn T, Mavrova-Risteska L, Ruckhäberle E, Gaetje R, Holtrich U, Kaufmann M, Rody A, Wiegratz I. SATB1 gene expression and breast cancer prognosis. Breast 2011; 20: 309-13.
14. Tu W, Luo M, Wang Z, Yan W, Xia Y, Deng H, He J, Han P, Tian D. Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer. Liver Int 2012; 32: 1064-78.
15. Huang B, Zhou H, Wang X, Liu Z. Silencing SATB1 with siRNA inhibits the proliferation and invasion of small cell lung cancer cells. Cancer Cell Int 2013; 13: 8.
16. Zhang H, Qu S, Li S, Wang Y, Li Y, Wang Y, Wang Z, Li R. Silencing SATB1 inhibits proliferation of human osteosarcoma U2OS cells. Mol Cell Biochem 2013; 378: 39-45.
17. Endo K, Shackelford J, Aga M, Yoshizaki T, Pagano JS. Upregulation of special AT-rich-binding protein 1 by Epstein-Barr virus latent membrane protein 1 in human nasopharyngeal cells and nasopharyngeal cancer. J Gen Virol 2013; 94: 507-13.
18. Shen Z, Zeng Y, Guo J, Wu Y, Jiang X, Ding R, Wu C, Li R, Luo B, Zeng C, Jiang H, Jie W. Over-expression of the special AT rich sequence binding protein 1 (SATB1) promotes the progression of nasopharyngeal carcinoma: association with EBV LMP-1 expression. J Transl Med 2013; 11: 217.